Completion of evaluation of bis-aminopropyl diglycol dimaleate
We have completed an evaluation about the human health risks associated with the introduction and use of 1-Propanamine, 3,3′-[oxybis(2,1-ethanediyloxy)]bis-, (2Z)-2-butenedioate (1:2) (also known as bis-aminopropyl diglycol dimaleate), which is currently under an assessment certificate.
This evaluation is issued by the AICIS Executive Director under section 73 of the Industrial Chemicals Act 2019 and is listed below.
Subject of evaluation: 1-Propanamine, 3,3′-[oxybis(2,1-ethanediyloxy)]bis-, (2Z)-2-butenedioate (1:2) (bis-aminopropyl diglycol dimaleate)
CAS number: 1629579-82-3
Proposed means for managing risks: Information relating to safe introduction and use
Download Evaluation Statement:
EVA00047 – Evaluation Statement – 28 February 2022 [478KB].pdf
Industrial Chemicals, 28-02-22